Kyle Dempsey
Directeur/Membre du Conseil chez OPTINOSE, INC.
Fortune : 6 089 $ au 30/04/2024
Profil
Kyle Dempsey currently works at OptiNose, Inc., as Independent Director from 2021, GT Medical Technologies, Inc., as Director, HLS Therapeutics, Inc., as Independent Director from 2022, and MVM Partners LLC, as Partner from 2017.
Dr. Dempsey received his undergraduate degree from Bowdoin College, doctorate degree from Harvard Medical School, and Masters Business Admin degree from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
0,01% | 31/03/2024 | 1 765 ( 0,01% ) | 6 089 $ | 30/04/2024 |
OPTINOSE, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Kyle Dempsey
| Sociétés | Poste | Début |
|---|---|---|
| OPTINOSE, INC. | Directeur/Membre du Conseil | 10/12/2021 |
| HLS THERAPEUTICS INC. | Directeur/Membre du Conseil | 29/11/2022 |
| MVM Partners LLC | Private Equity Investor | 01/09/2017 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Directeur/Membre du Conseil | - |
Formation de Kyle Dempsey
| Bowdoin College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| MVM Partners LLC | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Health Technology |